Literature DB >> 3677302

Doxorubicin concentration time course in the myocardium after single administration to the dog. Possible role in the cardiac effects.

Q Timour1, P Nony, J Lang, M Lakhal, V Trillet, G Faucon.   

Abstract

Three hours after i.v. administration of doxorubicin, concentrations of the drug in the myocardium are much higher (about 50 times) and decrease much more slowly (drug still detected 21 days later) than those in the plasma, so that storage results from too early readministration, with possible toxic signs.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3677302     DOI: 10.1007/bf00570501

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  21 in total

1.  A simple drill-biopsy technique: evaluation for muscular and myocardial biochemical measurements.

Authors:  K Schwartz; P Rey; M de Mendonca
Journal:  J Mol Cell Cardiol       Date:  1973-06       Impact factor: 5.000

2.  Transport and storage of daunorubicin and doxorubicin in cultured fibroblasts.

Authors:  C Peterson; A Trouet
Journal:  Cancer Res       Date:  1978-12       Impact factor: 12.701

3.  Cellular pharmacokinetics of daunorubicin: uptake by leukaemic cells in vivo and fate.

Authors:  V Trillet; M Lakhal; J Lang; E Perrin-Fayolle; Q Timour Chah; D Fière; G Faucon
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

4.  The effect of vivo doxorubicin (adriamycin) and aclacinomycin administration on guanylate cyclase activity in rat tissue.

Authors:  D C Lehotay; B A Levey; B J Rogerson; G S Levey
Journal:  Proc Soc Exp Biol Med       Date:  1981-09

5.  Early phase pharmacokinetics of doxorubicin (adriamycin) in plasma of cancer patients during single- or multiple-drug therapy.

Authors:  E Piazza; M G Donelli; M Broggini; C Sessa; N Natale; L Ottolenghi; S Marsoni; A Libretti; C Mangioni; L Morasca
Journal:  Cancer Treat Rep       Date:  1980 Aug-Sep

6.  Adriamycin and daunomycin generate reactive oxygen compounds in erythrocytes.

Authors:  C A Henderson; E N Metz; S P Balcerzak; A L Sagone
Journal:  Blood       Date:  1978-11       Impact factor: 22.113

7.  Tissue disposition of doxorubicin in experimental animals.

Authors:  Y T Lee; K K Chan; P A Harris
Journal:  Med Pediatr Oncol       Date:  1982

Review 8.  [Selective toxicity of cytostatic agents: studies on the cardiotoxicity of doxorubicin, its pathogenesis and contraindications].

Authors:  R Lenzhofer
Journal:  Wien Klin Wochenschr Suppl       Date:  1983

9.  Determination of daunorubicin and its main metabolites in plasma, urine and leukaemic cells in patients with acute myeloblastic leukaemia.

Authors:  C Paul; R Baurain; G Gahrton; C Peterson
Journal:  Cancer Lett       Date:  1980-06       Impact factor: 8.679

10.  Relation between cardiotoxic effect of adriamycin and superoxide anion radical.

Authors:  T Adachi; T Nagae; Y Ito; K Hirano; M Sugiura
Journal:  J Pharmacobiodyn       Date:  1983-02
View more
  2 in total

Review 1.  Antibody-targeted polymer-bound drugs.

Authors:  B Ríhová
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

Review 2.  Clinical pharmacokinetics of doxorubicin.

Authors:  P A Speth; Q G van Hoesel; C Haanen
Journal:  Clin Pharmacokinet       Date:  1988-07       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.